| Entry |
|
|---|
| Name |
Procarbazine hydrochloride (JP18/USP);
Matulane (TN) |
|---|
| Product |
|
|---|
| Formula |
C12H19N3O. HCl
|
|---|
| Exact mass |
257.1295
|
|---|
| Mol weight |
257.7597
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Therapeutic category: | 4291 |
| Product (DG00706): | D00478<JP/US> |
|
|---|
| Efficacy |
Antineoplastic |
|---|
| Disease |
|
|---|
| Target |
DNA |
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XB Methylhydrazines
L01XB01 Procarbazine
D00478 Procarbazine hydrochloride (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Alkylating Agents
Procarbazine
D00478 Procarbazine hydrochloride (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D00478 Procarbazine hydrochloride (JP18/USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00478 Procarbazine hydrochloride
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C8y C 24.2206 -18.2647
2 C5a C 25.4532 -19.0008
3 C8x C 24.2206 -16.8744
4 C8x C 23.0289 -18.9657
5 N1b N 26.6508 -18.3115
6 O5a O 25.4532 -20.4085
7 C8x C 23.0289 -16.1734
8 C8x C 21.8079 -18.2530
9 C1c C 27.8658 -19.0301
10 C8y C 21.8079 -16.8744
11 C1a C 27.8658 -20.4085
12 C1a C 29.0691 -18.3348
13 C1b C 20.5753 -16.1326
14 N1b N 19.3546 -16.8102
15 N1b N 18.1628 -16.0917
16 C1a C 16.9362 -16.7927
17 X Cl 32.5984 -19.0384
BOND 16
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 2
6 3 7 1
7 4 8 2
8 5 9 1
9 7 10 2
10 9 11 1
11 9 12 1
12 10 13 1
13 13 14 1
14 14 15 1
15 15 16 1
16 8 10 1
|
|---|
